Literature DB >> 23360884

Gut microbiota and metabolic disorders: How prebiotic can work?

Nathalie M Delzenne1, Audrey M Neyrinck, Patrice D Cani.   

Abstract

Experimental data in animals, but also observational studies in obese patients, suggest that the composition of the gut microbiota differs in obese v. lean individuals, in diabetic v. non-diabetic patients or in patients presenting other diseases associated with obesity or nutritional dysbalance, such as non-alcoholic steatohepatitis. In the present review, we will describe how changes in the gut microbiota composition and/or activity by dietary fibres with prebiotic properties, can modulate host gene expression and metabolism. We will evaluate their potential relevance in the management of obesity and related metabolic disturbances, in view of the experimental data and intervention studies published up to date.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23360884     DOI: 10.1017/S0007114512004047

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  54 in total

Review 1.  Towards a more comprehensive concept for prebiotics.

Authors:  Laure B Bindels; Nathalie M Delzenne; Patrice D Cani; Jens Walter
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-31       Impact factor: 46.802

2.  Dietary Polysaccharides in the Amelioration of Gut Microbiome Dysbiosis and Metabolic Diseases.

Authors:  Shokouh Ahmadi; Rabina Mainali; Ravinder Nagpal; Mahmoud Sheikh-Zeinoddin; Sabihe Soleimanian-Zad; Shaohua Wang; Gagan Deep; Santosh Kumar Mishra; Hariom Yadav
Journal:  Obes Control Ther       Date:  2017-12-18

3.  Obese Mice Fed a Diet Supplemented with Enzyme-Treated Wheat Bran Display Marked Shifts in the Liver Metabolome Concurrent with Altered Gut Bacteria.

Authors:  Dorothy A Kieffer; Brian D Piccolo; Maria L Marco; Eun Bae Kim; Michael L Goodson; Michael J Keenan; Tamara N Dunn; Knud Erik Bach Knudsen; Sean H Adams; Roy J Martin
Journal:  J Nutr       Date:  2016-10-19       Impact factor: 4.798

4.  Gastrointestinal microbiome modulator improves glucose tolerance in overweight and obese subjects: A randomized controlled pilot trial.

Authors:  Candida J Rebello; Jeffrey Burton; Mark Heiman; Frank L Greenway
Journal:  J Diabetes Complications       Date:  2015-09-03       Impact factor: 2.852

Review 5.  Gut microbiota and GLP-1.

Authors:  Amandine Everard; Patrice D Cani
Journal:  Rev Endocr Metab Disord       Date:  2014-09       Impact factor: 6.514

6.  Targeting Kupffer cells in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why and how?

Authors:  Nicolas Lanthier
Journal:  World J Hepatol       Date:  2015-09-08

Review 7.  Breath volatile organic compounds for the gut-fatty liver axis: promise, peril, and path forward.

Authors:  Steven Francis Solga
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

8.  Postnatal prebiotic fibre intake mitigates some detrimental metabolic outcomes of early overnutrition in rats.

Authors:  Danielle T Reid; Lindsay K Eller; Jodi E Nettleton; Raylene A Reimer
Journal:  Eur J Nutr       Date:  2015-09-25       Impact factor: 5.614

9.  Gut microbial metabolites of polyunsaturated fatty acids correlate with specific fecal bacteria and serum markers of metabolic syndrome in obese women.

Authors:  Céline Druart; Evelyne M Dewulf; Patrice D Cani; Audrey M Neyrinck; Jean-Paul Thissen; Nathalie M Delzenne
Journal:  Lipids       Date:  2014-01-29       Impact factor: 1.880

Review 10.  Resistant starch: promise for improving human health.

Authors:  Diane F Birt; Terri Boylston; Suzanne Hendrich; Jay-Lin Jane; James Hollis; Li Li; John McClelland; Samuel Moore; Gregory J Phillips; Matthew Rowling; Kevin Schalinske; M Paul Scott; Elizabeth M Whitley
Journal:  Adv Nutr       Date:  2013-11-06       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.